Avid Bioservices, Inc. - Common Stock (CDMO)
12.49
0.00 (0.00%)
Avid Bioservices Inc is a biotechnology company focused on providing comprehensive biomanufacturing solutions for the development and production of complex biologics, including monoclonal antibodies and other therapeutic proteins
The company serves a diverse range of clients, including pharmaceutical and biotechnology firms, by offering a wide array of services that encompass process development, scale-up, and cGMP (current Good Manufacturing Practice) production. Avid Bioservices is dedicated to advancing the field of biopharmaceuticals through its expertise in cell culture development and regulatory compliance, ultimately supporting the successful commercialization of innovative therapies for various diseases.
![](https://cdn.benzinga.com/files/images/story/2024/11/07/Hersheys.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 7, 2024
![](https://cdn.benzinga.com/files/images/story/2024/09/10/Energy-stocks.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 10, 2024
![](https://cdn.benzinga.com/files/images/story/2024/09/10/Ecco-3-azioni-hanno-che-attirato-lattenz.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 10, 2024
![](https://cdn.benzinga.com/files/images/story/2024/09/10/Movers.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 10, 2024
![](https://cdn.benzinga.com/files/images/story/2024/07/03/man-5710164-1280.jpeg?width=1200&height=800&fit=crop)
Avid reported fourth quarter financial results on Tuesday after the market closed. The company reported a loss of $1.94 per share missing analyst estimates of a loss of 4 cents per share.
Via Benzinga · July 3, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
CDMO stock results show that Avid Bioservices beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.
Via InvestorPlace · July 2, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/21/movers-image_12.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 21, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/21/movers-image_11.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 21, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 11, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
CDMO stock results show that Avid Bioservices missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024.
Via InvestorPlace · April 24, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/07/image41.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 250 points on Thursday. The Dow traded up 0.34% to 38,793.79 while the NASDAQ rose 1.63% to 16,292.61. The S&P 500 also rose, gaining, 1.06% to 5,158.91.
Via Benzinga · March 7, 2024
![](https://cdn.benzinga.com/files/images/story/2024/CDMO-Logo.png?width=1200&height=800&fit=crop)
Avid Bioservices' Q3 fiscal 2024 report: $33.8 million revenues, 11% Y/Y decrease, $41 million new orders, $206 million backlog. Operating loss at $4 million. Completed CGT facility. Fiscal year 2024 revenue guidance: $137-$147 million.
Via Benzinga · March 7, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/07/image49_0.jpg?width=1200&height=800&fit=crop)
Shares of HighPeak Energy, Inc. (NASDAQHPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Via Benzinga · March 7, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/07/image30_0.jpeg?width=1200&height=800&fit=crop)
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 1% on Thursday. The Dow traded up 0.26% to 38,762.00 while the NASDAQ rose 1.38% to 16,253.50. The S&P 500 also rose, gaining, 0.91% to 5,151.16.
Via Benzinga · March 7, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · March 7, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/07/bjs_wholesale_-_logo_copy.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.47% to 38,843.54 while the NASDAQ rose 0.66% to 16,137.37. The S&P 500 also rose, gaining, 0.57% to 5,134.03.
Via Benzinga · March 7, 2024
![](https://investorplace.com/wp-content/uploads/2022/02/mnmd_mushrooms_1600.png)
MindMed stock is heading higher on Thursday as MNMD investors celebrate it getting breakthrough designation from the FDA!
Via InvestorPlace · March 7, 2024
![](https://investorplace.com/wp-content/uploads/2019/08/nvo-stock.jpg)
Novo Nordisk stock is gaining on Thursday as NVO investors react to positive news from its new weight loss drug clinical trial.
Via InvestorPlace · March 7, 2024
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
Avid Bioservices stock is falling on Thursday after the company priced CDMO shares in a $160 million private placement for senior notes.
Via InvestorPlace · March 7, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · March 7, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/07/image49.jpg?width=1200&height=800&fit=crop)
Shares of Rush Street Interactive, Inc. (NYSERSI) rose sharply in today’s pre-market trading as the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for 2024.
Via Benzinga · March 7, 2024
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
Pre-market stock movers are worth checking out on Thursday to get an idea of the hottest stocks worth watching this morning!
Via InvestorPlace · March 7, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/07/victorias_secret_-_logo.jpg?width=1200&height=800&fit=crop)
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 0.1% points on Thursday.
Via Benzinga · March 7, 2024
![](https://cdn.benzinga.com/files/images/story/2024/01/26/booz_allen_hamilton_-logo.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday.
Via Benzinga · January 26, 2024